During the past decade, Praxis für gynäkologische Onkologie am Ev. Krankenhaus Bethesda conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Praxis für gynäkologische Onkologie am Ev. Krankenhaus Bethesda" #1 collaborator was "Genomic Health®, Inc." with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "NanoString Technologies, Inc." with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Praxis für gynäkologische Onkologie am Ev. Krankenhaus Bethesda" are "Breast Cancer" (1 trials) and "Breast Cancer Female" (1 trials). Many other conditions were trialed in "Praxis für gynäkologische Onkologie am Ev. Krankenhaus Bethesda" in a lesser frequency.

Most popular intervention types in "Praxis für gynäkologische Onkologie am Ev. Krankenhaus Bethesda" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (1 trials), "Pertuzumab" (1 trials), "Ribociclib 200Mg Oral Tablet" (1 trials) and "Trastuzumab Biosimilar ABP 980" (1 trials). Other intervention names were less common.

The vast majority of trials in "Praxis für gynäkologische Onkologie am Ev. Krankenhaus Bethesda" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Praxis für gynäkologische Onkologie am Ev. Krankenhaus Bethesda". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Praxis für gynäkologische Onkologie am Ev. Krankenhaus Bethesda, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Praxis für gynäkologische Onkologie am Ev. Krankenhaus Bethesda, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".